MS Speaks

Multiple Sclerosis => TREATMENTS => TECFIDERA (dimethyl fumarate, BG-12, Fumaderm) => Topic started by: agate on March 18, 2019, 08:25:17 am

Title: (Abst.) Tecfidera better at preventing relapses than Aubagio
Post by: agate on March 18, 2019, 08:25:17 am
This study, published in Neurology, showed Tecfidera to be better than Aubagio at preventing relapses and less likely to be discontinued due to disease breakthrough: From PubMed, March 17, 2019--"Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study":


https://www.ncbi.nlm.nih.gov/pubmed/30877188